Marc Carrier/LinkedIn
Jul 18, 2026, 15:40
Marc Carrier: New ISTH 2026 Data May Simplify DVT Evaluation During Pregnancy
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared on LinkedIn:
”New data presented at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris!
Dr. Marc Rodger presented the LEFt study results.
Key findings from this prospective multinational study:
- An ‘unlikely’ LEFt score combined with a negative D-dimer safely excluded DVT without the need for ultrasound imaging.
- None of the patients meeting these criteria experienced an initial or follow-up venous thromboembolism.
- A ‘likely’ LEFt score identified a subgroup at substantially higher risk, with nearly 28% diagnosed with VTE.
These findings represent an important step toward a more individualized, evidence-based approach to the evaluation of suspected DVT in pregnancy.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease